Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNSS
DateTimeSourceHeadlineSymbolCompany
03/07/20194:01PMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
03/04/20193:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/04/20197:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:SNSSSunesis Pharmaceuticals Inc
02/28/20197:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on March 7th to Discuss Fourth Quarter and Full-Year 2018 Financial Results a...NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/14/20195:00PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/14/20194:59PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/14/201912:18PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/13/201912:27PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/04/20195:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/28/20195:24PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/25/201911:54AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/24/20195:25PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/24/20195:23PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/22/20196:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/22/20196:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/22/20196:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/17/20199:58PMGlobeNewswire Inc.Sunesis Announces Pricing of $20 Million Offering of SecuritiesNASDAQ:SNSSSunesis Pharmaceuticals Inc
01/17/20194:22PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/17/20194:18PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/17/20194:05PMGlobeNewswire Inc.Sunesis Announces Proposed Public Offering of Common Stock and Preferred StockNASDAQ:SNSSSunesis Pharmaceuticals Inc
01/11/20195:28PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/07/20199:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/02/20197:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Advancement into 100mg Cohort of Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and ...NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/12/20184:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/03/20182:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/02/201812:00PMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentation of Preliminary Data from Phase 1b/2 Trial of Vecabrutinib in Patients with CLL...NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/28/20187:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Provide Program Update for Non-Covalent BTK-Inhibitor Vecabrutinib at Analyst & Investor Event dur...NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/19/20187:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare ConferenceNASDAQ:SNSSSunesis Pharmaceuticals Inc
11/05/20184:47PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/05/20184:22PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNSS